日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neoadjuvant Abemaciclib plus Letrozole Versus Chemotherapy in Patients with HR+/HER2- Highly Proliferative Breast Cancer

新辅助阿贝西利联合来曲唑与化疗治疗HR+/HER2-高增殖性乳腺癌患者的疗效比较

Martín, Miguel; Guerrero-Zotano, Ángel L; Pérez-López, María E; Ruiz-Borrego, Manuel; Martínez Jáñez, Noelia; Chacón, José I; Gil-Gil, Miguel; Andrés, Raquel; Bermejo, Begoña; Sánchez-Rovira, Pedro; Del Barco, Sonia; Ponce, José J; Fernández, Isaura; Martínez de Dueñas, Eduardo; Hinojo-González, Carmen; González, Marta; García-Garre, Elisa; Hernando, Blanca; de la Haba-Rodriguez, Juan; Álvarez, Isabel M; González-Santiago, Santiago; García-Sáenz, José Á; Santaballa, Ana; Casas, Maribel; Bezares, Susana; Caballero, Rosalía; Rojo, Federico; Alba, Emilio

Clinical subtypes in breast cancer patients with brain metastases from an ambispective registry of advanced breast cancer, GEICAM/2014-03 (RegistEM)

来自晚期乳腺癌前瞻性登记研究GEICAM/2014-03(RegistEM)的乳腺癌脑转移患者的临床亚型

López-Tarruella, Sara; Guerrero-Zotano, Ángel; Antolín, Silvia; Cruz, Josefina; Martínez, Purificación; Rodríguez, César A; Falo, Catalina; Rodríguez-Lescure, Álvaro; Adrover, Encarna; Hernández, María; Andrés, Raquel; Chacón, José Ignacio; Alonso Romero, José Luis; Miguel, Ana; Gómez-Raposo, César; Margelí, Mireia; González, Iria; Guerra, Juan Antonio; Antón, Antonio; Tibau, Ariadna; Miralles, Juan José; Escudero, María José; Bezares, Susana; Rojo, Federico; Álvarez, Isabel

Second Line Treatment Decision as Per Standard of Care or Foundation Medicine in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

局部晚期或转移性非小细胞肺癌患者的二线治疗决策,遵循标准治疗方案或基础医学原则

Rojo, Federico; Felip, Enriqueta; Juan Vidal, Oscar; García Campelo, Rosario; Aguiar Bujanda, David; Terrasa Pons, Josefa; López-Castro, Rafael; Calles, Antonio; Paredes Lario, Alfredo; Bernabé Caro, Reyes; Barneto Aranda, Isidoro; García-Palacios, Luis; De Castro Carpeño, Javier

FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA Trial

GEICAM_CIBOMA试验结果显示,FOXC1表达可预测卡培他滨对三阴性乳腺癌患者的疗效

Rojo, Federico; Taylor, Clive R; Barrios, Carlos; Torrecillas, Laura; Ruiz-Borrego, Manuel; Perez-Buira, Sandra; Bines, Jose; Guerrero-Zotano, Angel; Garcia-Saenz, Jose A; Torres, Roberto; de la Haba-Rodriguez, Juan; Ayala, Francisco; Gomez, Henry; Llombart, Antonio; Rodriguez de la Borbolla, Maria; Baena-Cañada, Jose Manuel; Barnadas, Agusti; Calvo, Lourdes; Herranz, Jesus; Rincon, Raul; Caballero, Rosalia; Bermejo, Begoña; Ray, Partha S; Martin, Miguel

Biomarkers of palbociclib response in hormone receptor-positive advanced breast cancer from the PARSIFAL trial

来自PARSIFAL试验的激素受体阳性晚期乳腺癌患者帕博西尼疗效的生物标志物

Albanell, Joan; Pozo, Angelo Gámez; Arteaga, Carlos L; Bellet, Meritxell; Rojo, Federico; González, Abel; Bellosillo, Beatriz; Serra, Violeta; Gener, Petra; Guerrero, José Antonio; Shimizu, Eileen; Mancino, Mario; Rodríguez-Morató, Jose; Mina, Leonardo; Pérez-García, José Manuel; Cortés, Javier; Llombart-Cussac, Antonio

BRCA1/2 and Other Predisposition Genes in High-Risk Hormone Receptor+/Human Epidermal Growth Factor Receptor 2- Breast Cancer Treated With Endocrine Therapy With or Without Palbociclib: A Secondary PENELOPE-B Study Analysis

BRCA1/2 和其他易感基因在接受内分泌治疗(含或不含帕博西尼)的高危激素受体阳性/人表皮生长因子受体 2 阴性乳腺癌患者中的作用:一项 PENELOPE-B 研究的二次分析

Hahnen, Eric; Hauke, Jan; Gelmon, Karen; Marmé, Frederik; Ernst, Corinna; Martin, Miguel; Untch, Michael; Bonnefoi, Hervé; Knudsen, Erik; Im, Seock-Ah; DeMichele, Angela; Van't Veer, Laura; Kim, Sung-Bae; Bear, Harry; McCarthy, Nicole; Rhiem, Kerstin; Turner, Nicholas; Witkiewicz, Agnieszka; Rojo, Federico; Filipits, Martin; Martin, Lesley-Ann; Fasching, Peter A; Schem, Christian; Becker, Kerstin; García-Sáenz, José A; Kelly, Catherine M; Reimer, Toralf; Toi, Masakazu; Rugo, Hope S; Denkert, Carsten; Gnant, Michael; Makris, Andreas; Liu, Yuan; Valota, Olga; Felder, Bärbel; Weber, Karsten; Nekljudova, Valentina; Loibl, Sibylle

Adaptive Proteomic Changes in Protein Metabolism and Mitochondrial Alterations Associated with Resistance to Trastuzumab and Pertuzumab Therapy in HER2-Positive Breast Cancer

HER2阳性乳腺癌对曲妥珠单抗和帕妥珠单抗治疗耐药相关的蛋白质代谢和线粒体改变的适应性蛋白质组学变化

Madoz-Gúrpide, Juan; Serrano-López, Juana; Sanz-Álvarez, Marta; Morales-Gallego, Miriam; Rodríguez-Pinilla, Socorro María; Rovira, Ana; Albanell, Joan; Rojo, Federico

CLDN18.2 expression in gastroesophageal adenocarcinoma: prevalence, heterogeneity, and prognostic implications in Spanish patients

CLDN18.2在胃食管腺癌中的表达:西班牙患者的患病率、异质性和预后意义

Martinez-Ciarpaglini, Carolina; Ortega, María; Pérez-Buira, Sandra; Bolea, Aitana; Casado Guerra, Beatriz; Herencia Bellido, Carmen; Tornero Piñero, Paula; Naranjo-Hans, Dolores; Palomar, Brenda; Quiceno, Hernán; Sardón Fernández, Amanda; Torner Calvo, Ariadna; Rojo, Federico; Iglesias Coma, Mar

Implementing digital pathology: qualitative and financial insights from eight leading European laboratories

实施数字化病理学:来自八家欧洲领先实验室的定性和财务见解

Matias-Guiu, Xavier; Temprana-Salvador, Jordi; Garcia Lopez, Pablo; Kammerer-Jacquet, Solene-Florence; Rioux-Leclercq, Nathalie; Clark, David; Schürch, Christian M; Fend, Falko; Mattern, Sven; Snead, David; Fusco, Nicola; Guerini-Rocco, Elena; Rojo, Federico; Brevet, Marie; Salto Tellez, Manuel; Dei Tos, Angelo; di Maio, Thomas; Ramírez-Peinado, Silvia; Sheppard, Elizabeth; Bannister, Huw; Gkiokas, Anastasios; Arpaia, Mario; Ben Dhia, Ons; Martino, Nazario

Effects of presurgical HIIT in hormone receptor-positive, HER 2-negative breast cancer cases: Two case reports from the GEICAM EFiK study

术前高强度间歇训练对激素受体阳性、HER2阴性乳腺癌患者的影响:来自GEICAM EFiK研究的两例病例报告

Pérez-Bilbao, Txomin; López-Tarruella, Sara; Alonso-Dueñas, María; San Juan, Alejandro F; Ferreres-García, Karla; Martín, Miguel; Peinado, Ana B; Rojo, Federico